New Novo Nordisk AI hub for drug discovery to open in London, UK

Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations.

A spokesperson for Novo Nordisk stated: “[The new facility] will accelerate innovation and collaboration to create and supply AI in the discovery and development of new potential drug candidates... it will represent a vibrant and diverse AI research ecosystem across fields including AI, data science, and engineering.” The AI research hub will also align with Novo Nordisk’s company aim to digitise processes across its business. The company stated that AI is already beginning to contribute to the research and development of new medicinal products. “[The hub will allow Novo Nordisk] to better collaborate with leading research institutions, big tech, and innovative start-ups and attract top talent,” Novo Nordisk’s spokesperson commented. 

Prior to this announcement, the company recently entered into a collaboration with Valo Health to discover and develop novel treatments for cardiometabolic diseases using AI. Novo Nordisk’s London AI hub will also align with the UK’s goal to position itself as an international hub for AI. The country has launched various initiatives such as a new AI Safety Institute last November.  

Source: Novo Nordisk to open new AI hub in UK for drug discovery [Accessed January 4, 2023] https://pharmatimes.com/news/novo-nordisk-to-open-new-ai-hub-in-uk-for-drug-discovery/